ABOUT VIGENENT

Microbial research is our starting point.

Vigenent is a company within Visgeneer Group focused on microbial research and ingredient development, exploring the connections between research and industry needs.

OUR APPROACH

Clear research. Specific conversations.

Start with the research material and its documentation, then connect that information to a specific development question.

01

Understand the research material

Identify the material, methods and conditions used in a study so its findings have a clear context.

02

Define the ingredient

Connect the ingredient brand, INCI identity and relevant technical information so teams can work from the same information.

03

Begin with the development need

Understand the product category, development stage and evaluation questions before discussing the next step.

Dr Ken-Shwo Dai, founder, chairman and general manager of Vigenent and Visgeneer
DR. KEN-SHWO DAI

FOUNDER & R&D LEADERSHIP

Dr Ken-Shwo Dai

Founder, Chairman and General Manager of Vigenent and Visgeneer

Dr Ken-Shwo Dai holds a PhD in medical sciences from the University of Toronto. Since founding Visgeneer Group and Vigenent, he has led teams connecting microbial research, fermentation, ingredient development and manufacturing resources to advance research toward practical product applications.

01

Research context

Build a continuing technical record around microorganisms, fermentation and ingredient research.

02

Application pathway

Connect research, ingredient identity and product needs within one development pathway.

03

Group capability

Extend research possibilities through Visgeneer's formulation, manufacturing and quality systems.

COMPANY MILESTONES

Building a research record since 2009.

From incorporation and research outcomes to ingredient nomenclature, Vigenent's progress is reflected in documented milestones.

  1. 2009.11.30

    Vigenent was established

    Vigenent Inc. was established, beginning its work in microbial research and ingredient development.

  2. 2016

    Patent grant and research publication

    European patent EP2441433B1 was granted, and related microbial zeaxanthin research was published in the same year.

  3. 2026

    INCI assignment recorded

    The INCI ingredients for VIGENENT Olleya were recorded, extending the research into ingredient applications.

COMPANY & INGREDIENT BRAND

Distinct roles within a shared research background.

01

Visgeneer Group

Visgeneer Group

The group to which Vigenent belongs.

03

Ollantein®

Ingredient brand

A branded ingredient developed from research involving Olleya marilimosa.

APPLICATION PERSPECTIVE

BOWIL, the group’s men’s skincare brand, offers a perspective on ingredients in daily skincare.

Explore BOWIL
European patent grant certificate, 2016, naming Vigenent Inc. as proprietorEP2441433B1 · 20 APR 2016

OUR RESEARCH FOUNDATION

Research documented in the company’s name.

The European patent grant documents name Vigenent Inc. as the proprietor. The 2016 research manuscript also lists Vigenent Inc. as the author’s affiliation. These records form part of Vigenent’s research history.

CONNECT WITH VIGENENT

Let your requirements guide the next conversation.

We welcome brand, formulation, research and procurement teams to share their current needs and ideas.